KOSDAQ-Listed Union Korea Pharm Issues Paid-In Capital Increase... Third-Party Allotment to Bukwang Pharmaceutical
Union Korea Pharm, a KOSDAQ-listed company, announced on the 18th that it has decided to issue new shares through a third-party allotment paid-in capital increase.
Hot Picks Today
!["10 Million Won Grows to 2.18 Billion"... 'Father of ETFs' Recommends This Stock for Grandchildren [KOSPI 10,000 Era]](https://cwcontent.asiae.co.kr/asiaresize/93/2026072114592552828_1784613565.jpg)
"10 Million Won Grows to 2.18 Billion"... 'Father of ETFs' Recommends This Stock for Grandchildren [KOSPI 10,000 Era]
- "Don't Quit, We'll Give You a 50 Million Won Bonus"...This Company Takes Drastic Measures to Retain Talent
- "$300 Gone in One Date"...U.S. Gen Z Ditches Restaurants for Parks
- "AI Optimism Reignites as KOSPI Reclaims 7000"
- 'Human Refrigerator' Developed in Japan to Protect Outdoor Workers from Extreme Heat
A total of 60 million new common shares will be issued at 500 won per share. The third-party allotment recipient is Bukwang Pharmaceutical Co., Ltd. (60 million shares).
This content was produced with the assistance of AI translation services.
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.
